The Annenberg Leadership and Management Speaker Series is an integral part of Harvey Mudd College’s commitment to encouraging students to lead with integrity. Endowed through a generous gift from The Walter and Leonore Annenberg Fund for Leadership Development, this series brings to campus accomplished individuals who are recognized, world-class leaders in their fields of endeavor. The lectures provide an engaging forum for senior executives to address pertinent leadership issues and to share their insights with the Harvey Mudd community.
Admission to this public lecture series is complimentary. Lectures are held on campus, 301 Platt Blvd., Claremont, California, 91711. A dessert reception follows each lecture.
Tuesday, March 24, 7 p.m., Drinkward Recital Hall
“Leadership and Character”
Stephen Luczo will discuss the underlying elements of character that he believes are fundamental for effective leadership. In today’s world of instant access to information that spans from the accurate to the inane, one needs a process for understanding and structuring information flow for effective communication and leadership. Luczo is an expert in organization structure and facilitating strategic intent. Over the last 20 years, Seagate has transformed the mass storage market through its strategy and execution in what is regarded as the most competitive business in the high technology industry.
Luczo has been instrumental in the success of Seagate since joining the data storage solutions provider in 1993. A director since 2000, Luczo has served as president and CEO since January 2009 and continues to serve as chairman of the board. Under his leadership, Seagate’s stock has appreciated by 1600 percent, making it one of the top five performing stocks in the S&P 500. Luczo has been ranked among the world’s top technology CEOs by Institutional Investor (2014) and Bloomberg (2013). His charitable ventures are focused on global environmental issues and programs to help at-risk children in the urban United States and the rural areas of Sicily. Luczo received his B.A. from Stanford and his MBA from Stanford University Graduate School of Business.
Tuesday, Feb. 17, 6 p.m., Green Room, Platt Campus Center
“Leadership, Innovation and Impact”
Dr. Sue Desmond-Hellmann will reflect on leadership lessons from her first year as chief executive officer of the Bill & Melinda Gates Foundation and from her prior experiences as a senior executive at Genentech and chancellor of the University of California at San Francisco. As a top manager of innovation leaders in the business, academic and philanthropic sectors, Desmond-Hellmann has developed unique insights into one of the most important questions facing organizations of all kinds in the 21st century: how to translate good ideas into useful impact.
Desmond-Hellmann leads the Bill & Melinda Gates Foundation’s efforts to promote equity for all people worldwide. An oncologist by training, Desmond-Hellmann is a recognized leader on issues of higher education, public health, drug development, regulatory innovation and health policy. Prior to joining the foundation in 2014, she was the first female chancellor of the University of California at San Francisco (UCSF), responsible for all aspects of the professional and graduate schools, medical center and research programs. Desmond-Hellmann also spent 14 years at Genentech, where she led the development and introduction of two of the first gene-targeted therapies for cancer, Avastin and Herceptin. A member of the board of directors at Procter & Gamble and Facebook, Desmond-Hellmann completed her undergraduate education and medical studies at the University of Nevada, Reno, followed by clinical training at UCSF. She is board-certified in internal medicine and medical oncology and holds an MPH from the University of California, Berkeley.
Tuesday, Feb. 3, 7 p.m., Drinkward Recital Hall
“Systems Medicine and a Longitudinal, Digital-Age Study of 100,000 Well Individuals: Revolutionizing Health Care”
Systems medicine, the application of systems biology to disease, has reached a tipping point and is already beginning to transform the practice of medicine. Three converging opportunities—systems medicine, big data (and its analytics) and patient-activated social networks—are leading to a proactive medicine that is predictive, personalized, preventive and participatory (P4). Hood will contrast P4 medicine with contemporary evidence-based medicine and discuss its societal implications for health care. He also will discuss his team’s plans to introduce P4 medicine into the current health care system with a longitudinal, digital-age study on 100,000 well patients.
Hood is a world-renowned scientist, inventor, entrepreneur and visionary. His discoveries have permanently changed the course of biology and revolutionized the understanding of genetics, life and human health. He developed automated technologies for analyzing proteins and genes that enabled the mapping of the human genome and revolutionized the field of genomics. He is a pioneer in the field of systems biology and has spent his career advancing an interdisciplinary systems approach to biological research and clinical medicine. Hood, a recipient of the 2012 National Medal of Science, received B.S. and PhD degrees from Caltech and an M.D. from the Johns Hopkins School of Medicine.